e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Regulatory mechanisms of cell activation, renewal and recruitment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effects of bortezomib on endothelial progenitor cells
T. Resch, H. Vogelsinger, J. Loeffler-Ragg, C. M. Kähler (Innsbruck, Austria)
Source:
Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment
Session:
Regulatory mechanisms of cell activation, renewal and recruitment
Session type:
Thematic Poster Session
Number:
684
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Resch, H. Vogelsinger, J. Loeffler-Ragg, C. M. Kähler (Innsbruck, Austria). The effects of bortezomib on endothelial progenitor cells. Eur Respir J 2008; 32: Suppl. 52, 684
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The effect of bortezomib (Velcade®) on endothelial progenitor cell functions
in vitro
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Targeting of endothelial progenitor cells with the proteasome inhibitor bortezomib
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009
The effect of Imatinib (Glivec®) on proliferation and angiogenesis of endothelial progenitor cells
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
Localisation of endothelial progenitor cells (EPC) in NSCLC patients and sensitivity of EPC to chemotherapeutic agents in vitro
Source: Eur Respir J 2004; 24: Suppl. 48, 4s
Year: 2004
Effect of endothelin-1 on migration of endothelial progenitor cells in vitro
Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment
Year: 2008
Thrombospondin-1 and endothelial progenitor cells
Source: Eur Respir J 2005; 26: Suppl. 49, 103s
Year: 2005
Effects of training on endothelial function and circulating endothelial progenitor cells in COPD patients
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Post-COVID-19 patients show an increased endothelial progenitor cell production
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021
Selective inhibition of COX-2 by celecoxib exerts negative effects on endothelial progenitor cell proliferation and stimulates apoptosis
in vitro
Source: Eur Respir J 2005; 26: Suppl. 49, 368s
Year: 2005
Distinct patterns of circulating endothelial cells in pulmonary hypertension
Source: Eur Respir J 2010; 36: 1284-1293
Year: 2010
Embryonic stem cells as source for endothelial cells for cell-based therapies
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Cell cooperation between human fibrocytes and endothelial progenitor cells during neoangiogenesis is driven by the CXCR4 pathway
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
Source: Eur Respir J 2011; 37: 1392-1399
Year: 2011
Stimulation of pulmonary smooth muscle cell proliferation by endothelial progenitor cells
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Lung-derived mesenchymal stem cells induce the secretion of hepatocyte growth factor in fibroblasts
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Profibrotic cytokine TGF-β1 increases endothelial progenitor cell angiogenic properties
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Evaluation of cadmium cytotoxicity using alveolar epithelial cells derived from human induced pluripotent stem cells
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept